{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:09:01Z","timestamp":1790834941045,"version":"4.1.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00189","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T04:14:29Z","timestamp":1518149669000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions"],"prefix":"10.3389","volume":"9","author":[{"given":"Edessa","family":"Negera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kidist","family":"Bobosha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas","family":"Bekele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birtukan","family":"Endale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeb","family":"Tarekegn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markos","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Aseffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel M.","family":"Dockrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana N.","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,9]]},"reference":[{"key":"B1","first-page":"355","article-title":"Classification of leprosy according to immmunity: five group system","volume":"34","author":"Ridley","year":"1966","journal-title":"Inter J Lepr Other Micobact Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e2690","DOI":"10.1371\/journal.pntd.0002690","article-title":"The mortality associated with erythema nodosum leprosum in Ethiopia: a retrospective hospital-based study","volume":"8","author":"Walker","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"868","DOI":"10.4269\/ajtmh.2006.74.868","article-title":"Clinical course of erythema nodosum leprosum: an 11-year chohort study in Hyderabad, India","volume":"74","author":"Pocaterra","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"B4","first-page":"8","article-title":"Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India","volume":"61","author":"Lockwood","year":"1993","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"B5","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/IAI.60.4.1441-1446.1992","article-title":"Tumor necrosis factor production in patients with leprosy","volume":"60","author":"Barnes","year":"1992","journal-title":"Infect Immun"},{"key":"B6","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.4049\/jimmunol.149.4.1470","article-title":"Cytokine patterns of immunologically mediated tissue damage","volume":"149","author":"Yamamura","year":"1992","journal-title":"J Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2249.2007.03485.x","article-title":"Serum levels of interferon-g, tumour necrosis factor-a, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions","volume":"150","author":"Iyer","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"B8","first-page":"705","article-title":"Evaluation of cytokine production in leprosy patients","volume":"56","author":"Fink","year":"1996","journal-title":"Medicina"},{"key":"B9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1046\/j.1365-4362.1998.00381.x","article-title":"Cytokines in leprosy, I. Serum cytokine profile in leprosy","volume":"37","author":"Moubasher","year":"1998","journal-title":"Int J Dermatol"},{"key":"B10","first-page":"385","article-title":"In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions","volume":"53","author":"Longley","year":"1985","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"B11","first-page":"235","article-title":"Defective intralesional interferon-gamma activity in patients with lepromatous leprosy","volume":"71","author":"Volc-Platzer","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"B12","first-page":"749","article-title":"Immunohistologic assessment of cytokine production of infiltrating cells in various forms of leprosy","volume":"137","author":"Arnoldi","year":"1990","journal-title":"Am J Pathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.1073\/pnas.0400339101","article-title":"Interleukin 2 plays a central role in Th2 differentiation","volume":"101","author":"Cote-Sierra","year":"2004","journal-title":"PNAS"},{"key":"B14","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1086\/429998","article-title":"Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept?","volume":"41","author":"Ehlers","year":"2005","journal-title":"Clin Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.4103\/0378-6323.42898","article-title":"Thechniques of immunofluorescence and thier siginificance","volume":"74","author":"Mohan","year":"2008","journal-title":"Indian J Dermatol Venereol Lepr"},{"key":"B16","first-page":"97","article-title":"Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae","volume":"86","author":"Misra","year":"1995","journal-title":"Immunology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0165-2478(00)00271-6","article-title":"The effect of antigen presenting cells on the cytokine profiles of stable and reactional lepromatous leprosy patients","volume":"75","author":"Nath","year":"2000","journal-title":"Immunol Lett"},{"key":"B18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.clindermatol.2014.07.005","article-title":"Immunology of leprosy and diagnostic challenges","volume":"33","author":"Nath","year":"2015","journal-title":"Clin Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1365-2567.1998.00634.x","article-title":"Lepromatous leprosy patients show T helper 1-like cytokine profile with differential expression of interleukin-10 during type 1 and 2 reactions","volume":"95","author":"Sreenivasan","year":"1998","journal-title":"Immunology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1046\/j.1523-1747.2000.00158.x","article-title":"Anti-inflammatory drugs block cytokine mRNA accumulation in the skin and improve the clinical condition of reactional leprosy patients","volume":"115","author":"Moraes","year":"2000","journal-title":"J Invest Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00403-002-0340-0","article-title":"Differential TNF\u03b1 mRNA regulation detected in the epidermis of leprosy patients","volume":"294","author":"Teles","year":"2002","journal-title":"Arch Dermatol Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1046\/j.1365-3083.1999.00622.x","article-title":"Cytokine mRNA expression in leprosy: a possible role for interferon-gamma and interleukin-12 in reactions (RR and ENL)","volume":"50","author":"Moraes","year":"1999","journal-title":"Cand J Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.5935\/0305-7518.20000084","article-title":"Dysregulation of IL-4 expression in lepromatous leprosy patients with and without erythema nodosum leprosum","volume":"71","author":"Nath","year":"2000","journal-title":"Lepr Rev"},{"key":"B24","first-page":"626","article-title":"Lessons of leprosy: the emergence of TH17 cytokines during type II reactions (ENL) is teaching us about T-cell plasticity","volume":"11","author":"Martiniuk","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00403-014-1486-2","article-title":"Serum Th17 cytokines in leprosy: correlation with circulating CD4(+) CD25 (high)FoxP3 (+) T-regs cells, as well as down regulatory cytokines","volume":"306","author":"Attia","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0004592","DOI":"10.1371\/journal.pntd.0004592","article-title":"Leprosy reactions show increased Th17\u2009cell activity and reduced FOXP3+ Tregs with concomitant decrease in TGF-\u03b2 and increase in IL-6","volume":"10","author":"Saini","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1128\/iai.73.6.3725-3733.2005","article-title":"Effects of prednisolone treatment on cytokine expression in patients with leprosy type 1 reactions","volume":"73","author":"Andersson","year":"2005","journal-title":"Infect Immun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0165-5728(97)00262-2","article-title":"Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse","volume":"85","author":"Gayo","year":"1998","journal-title":"J Neuroimmunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1164\/ajrccm.165.7.2106014","article-title":"Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids","volume":"165","author":"Meduri","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1046\/j.1365-2133.2001.03970.x","article-title":"Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient","volume":"144","author":"Moraes","year":"2001","journal-title":"Br J Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1046\/j.1365-2249.2000.01376.x","article-title":"Production of transforming growth factor-beta 1 (TGF-\u03b21) by blood monocytes from patients with different clinical forms of leprosy","volume":"122","author":"Goulart","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"B32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.47276\/lr.79.3.254","article-title":"Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatement with prednisolone or thalidomide","volume":"79","author":"Feuth","year":"2008","journal-title":"Lepr Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e2773","DOI":"10.1371\/journal.pntd.0002773","article-title":"T-cell regulation in lepromatous leprosy","volume":"8","author":"Bobosha","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0006001","DOI":"10.1371\/journal.pntd.0006001","article-title":"T-cell regulation in erythema nodosum leprosum","volume":"11","author":"Negera","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"B35","article-title":"Cryopreservation and thawing of mammalian cells","volume-title":"eLS","author":"Thompson","year":"2001"},{"key":"B36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1471-2199-8-113","article-title":"Relative quantification of mRNA: comparison of methods currently used for real-time PCR data analysis","volume":"8","author":"Cikos","year":"2007","journal-title":"BMC Mol Biol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/clin.1993.1065","article-title":"In vitro tumor necrosis factor production by mononuclear cells from lepromatous leprosy patients and from patients with erythema nodosum leprosum","volume":"67","author":"Santos","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1046\/j.1365-2249.1998.00510.x","article-title":"Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-\u03b1) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL)","volume":"111","author":"Sampaio","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1327","DOI":"10.1371\/journal.pntd.0001327","article-title":"Cytokine and protein markers of leprosy reactions in skin and nerves: baseline results for the North Indian INFIR Cohort","volume":"5","author":"Lockwood","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"B40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.47276\/lr.82.4.371","article-title":"Serum cytokine profile in leprosy and its correlation with clinico-histopathological profile","volume":"82","author":"Madan","year":"2011","journal-title":"Lepr Rev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1086\/498216","article-title":"Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation","volume":"192","author":"Haslett","year":"2005","journal-title":"J Infect Dis"},{"key":"B42","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4269\/ajtmh.2005.72.518","article-title":"A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum","volume":"72","author":"Villahermosa","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"B43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1471-2334-9-75","article-title":"Potential plasma markers of type 1 and type 2 leprosy reactions: a preliminary report","volume":"9","author":"Stefani","year":"2009","journal-title":"BMC Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1084\/jem.169.5.1565","article-title":"Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization","volume":"169","author":"Cooper","year":"1989","journal-title":"JEM"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1084\/jem.175.6.1729","article-title":"Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients","volume":"175","author":"Sampaio","year":"1992","journal-title":"J Exp Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0065-2776(08)60428-9","article-title":"Interferon-gamma: biology and role in pathogenesis","volume":"62","author":"Billiau","year":"1996","journal-title":"Adv Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1590\/S0100-879X1998000100009","article-title":"Expression and cytokine secretion in the states of immune reactivation in leprosy","volume":"31","author":"Sampaio","year":"1998","journal-title":"Braz J Med Biol Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.immuni.2012.10.010","article-title":"Interferon-\u03b3 excess leads to pathogenic accumulation of follicular helper T cells and germinal centers","volume":"37","author":"Lee Sau","year":"2012","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e27289","DOI":"10.1371\/journal.pone.0027289","article-title":"Up-regulation of Th17\u2009cells may underlie inhibition of Treg development caused by immunization with activated syngeneic T cells","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0304-3940(94)90933-4","article-title":"Penetration of interleukin-6 across the murine blood-brain barrier","volume":"179","author":"Banks","year":"1994","journal-title":"Neurosci Lett"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/infdis\/jis208","article-title":"Genetic and immunological evidence implicates interleukin 6 as a susceptibility gene for leprosy type 2 reaction","volume":"205","author":"Sousa","year":"2012","journal-title":"J Infect Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/jlb.56.5.559","article-title":"Essential involvement of interleukin-8 (IL-8) in acute inflammation","volume":"56","author":"Harada","year":"1994","journal-title":"J Leukoc Biol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1038\/emi.2013.58","article-title":"IL-17 cytokines in immunity and inflammation","volume":"2","author":"Jin","year":"2013","journal-title":"Emerg Microbes Infect"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00189\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T22:36:25Z","timestamp":1693521385000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00189\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,9]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2018.00189"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00189","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,9]]},"article-number":"189"}}